SETHURAMAN NATARAJAN (Chief Scientific Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/4/2025ACC: 0001873394-25-000003
Officer· Chief Scientific Officer
Since Oct 2021
-1.76K
Net shares
Net seller
$9.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.76K
Price / share
$5.43
Trade value
$9.56K
% of position
0.9%
9/2/2025
199.66K→197.90K
Total
Net shares
−1.76K
Net value
-$9.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | F · Tax Withholding | −1.76K | $5.43 | $9.56K | 0.9% | 199.66K | 197.90K |
| Total | −1.76K | -$9.56K | ||||||
Derivative Transactions0
No derivative transactions reported